syngo.MR OncoCare1 is your new tool for advanced oncology reading, designed to positively address therapy benefit.
With its histogram analysis, back-mapping, and trending functionalities, syngo.MR OncoCare offers a solution for quantitative evaluation of functional lesion response to treatment. It has the potential to allow earlier assessment of treatment response, leading to treatment path optimization and savings of unnecessary treatment costs.
1syngo.via VB10 and the syngo.via based software options are currently under development; not for sale in the U.S. and other countries. Future availability cannot be guaranteed.